Skip to content

KORU MEDICAL SYSTEMS, INC.: 10-K filed 2013-05-29

What KORU MEDICAL SYSTEMS, INC. reported in its annual report filed 2013-05-29 (fiscal FY 2012): 42 published measures, 84 facts as tagged in accession 0001161697-13-000351.

This filing

Form
10-K (annual report)
Filed
2013-05-29
Fiscal period
fiscal FY 2012
Accession
0001161697-13-000351 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KORU MEDICAL SYSTEMS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-02-285,592,225USD
At 2012-02-294,805,145USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-02-281,235,634USD
At 2012-02-291,254,417USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-02-284,356,591USD
At 2012-02-293,550,728USD
At 2011-02-282,480,460USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-02-281,930,321USD
At 2012-02-291,757,223USD
At 2011-02-281,322,250USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-03-01 to 2013-02-28725,763USD365
2011-03-01 to 2012-02-29815,893USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-03-01 to 2013-02-28784,790USD365
2011-03-01 to 2012-02-29560,601USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-03-01 to 2013-02-28563,567USD365
2011-03-01 to 2012-02-29236,235USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-03-01 to 2013-02-28-43,494USD365
2011-03-01 to 2012-02-29213,436USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-03-01 to 2013-02-28-568,198USD365
2011-03-01 to 2012-02-29-339,064USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-02-28780,530USD
At 2012-02-2954,767USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-03-01 to 2013-02-2836,011,448shares365
2011-03-01 to 2012-02-2934,250,560shares366

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-03-01 to 2013-02-2836,036,362shares365
2011-03-01 to 2012-02-2935,102,446shares366

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-03-01 to 2013-02-280.02USD/shares365
2011-03-01 to 2012-02-290.02USD/shares366

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-03-01 to 2013-02-280.02USD/shares365
2011-03-01 to 2012-02-290.02USD/shares366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-03-01 to 2013-02-28312,347USD365
2011-03-01 to 2012-02-29465,291USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-02-28875,986USD
At 2012-02-29498,940USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-03-01 to 2013-02-2880,100USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-03-01 to 2013-02-281,062,404USD365
2011-03-01 to 2012-02-291,289,158USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-02-284,632,957USD
At 2012-02-294,253,536USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-03-01 to 2013-02-2828,280USD365
2011-03-01 to 2012-02-2931,540USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-02-28525,359USD
At 2012-02-29558,853USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-02-28110,358USD
At 2012-02-29199,527USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-02-281,114,847USD
At 2012-02-29884,727USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-02-281,150,129USD
At 2012-02-291,167,456USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-03-01 to 2013-02-283,543,889USD365
2011-03-01 to 2012-02-292,655,668USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-03-01 to 2013-02-28147,576USD365
2011-03-01 to 2012-02-2990,329USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-02-2836,661,667shares
At 2012-02-2935,196,667shares

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2013-02-28439,306USD
At 2012-02-29482,800USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-02-282,477,984USD
At 2012-02-291,914,417USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-02-281,601,998USD
At 2012-02-291,415,477USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-02-2822,913USD
At 2012-02-2924,513USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-02-2883,282USD
At 2012-02-2952,669USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-02-28169,790USD
At 2012-02-29153,800USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-03-01 to 2013-02-281,038,110USD365
2011-03-01 to 2012-02-291,281,184USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-03-01 to 2013-02-28186,521USD365
2011-03-01 to 2012-02-2998,655USD366

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-03-01 to 2013-02-28190,971USD365
2011-03-01 to 2012-02-29103,981USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-03-01 to 2013-02-28-24,294USD365
2011-03-01 to 2012-02-29-7,974USD366

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2012-03-01 to 2013-02-2882,637USD365
2011-03-01 to 2012-02-29167,004USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-03-01 to 2012-02-29121,500USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-03-01 to 2013-02-28230,120USD365
2011-03-01 to 2012-02-29170,821USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-03-01 to 2013-02-28-17,327USD365
2011-03-01 to 2012-02-29499,256USD366

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-03-01 to 2013-02-28-89,169USD365
2011-03-01 to 2012-02-2941,419USD366

Inspect the source

Entity
KORU MEDICAL SYSTEMS, INC. / CIK 0000704440
Captured
2026-09-19T14:58:00.731Z
SEC response SHA-256
b53967f6fe0da17327c3bbc894c28ecf420f6c43e7707a871a63a9c303887166

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000704440.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))